The Genomic Research and Accessibility Act - aiming to curb the gold rush on patenting human genes - is making its way through Congress. As of now, 20% of the human genome has been patented, which stymies research and gives individuals and corporations unprecedented power over humanity. You can do you part and show your support for Representatives Becerra's (D-CA) and Weldons' (R-FL) bill by sending a fax this week to the address below. More information on this issue can be found here.
The Honorable Xavier Becerra
United States House of Representatives
1119 Longworth House Office Building
Washington, D.C. 20515
fax 202.225.2202
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
Imagine a world where everything from plastics to concrete is produced from biomass. Personalized cell and gene therapies prevent pandemics and treat previously incurable genetic diseases. Meat is lab-grown; enhanced nutrient grains are climate-resistant. This is what the future could...
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.